21 Aug 2025
// INDPHARMAPOST
https://www.indianpharmapost.com/news/natco-launches-bosentan-tablets-for-oral-suspension-in-us-with-180-day-exclusivity-17635
10 Jun 2025
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213981
05 Feb 2025
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213154
25 Jan 2020
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211461
24 Jan 2020
// EQUITYBULLS
16 Jan 2020
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205173